Glycoprotein conjugate vaccines (Q33743653)

29 July 2017

1 reference

title

Glycoprotein conjugate vaccines (English)

1 reference

29 July 2017

Lindberg AA

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

17 Suppl 2

1 reference

29 July 2017

page(s)

S28-36

1 reference

THE INFLUENCE OF DOSAGE AND ROUTE OF INJECTION ON THE ANTIBODY RESPONSE OF HUMAN SUBJECTS TO THE SPECIFIC CARBOHYDRATE OF THE TYPE VIII PNEUMOCOCCUS

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : I. OBSERVATIONS ON THE VIRULENT, ATTENUATED, AND AVIRULENT VARIANTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

THE ACTION OF TYPE-SPECIFIC HEMOPHILUS INFLUENZAE ANTISERUM.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

STUDIES ON ANTIBACTERIAL IMMUNITY INDUCED BY ARTIFICIAL ANTIGENS : I. IMMUNITY TO EXPERIMENTAL PNEUMOCOCCAL INFECTION WITH AN ANTIGEN CONTAINING CELLOBIURONIC ACID

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Spectrum of invasive Haemophilus influenzae type b disease in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Interactive effect of genes associated with immunoglobulin allotypes and HLA specificities on susceptibility to Haemophilus influenzae disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Correlation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in Caucasian adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

InvasiveHaemophilus influenzaeType b (Hib) Infection in an Adult Patient with a Selective Deficiency of Antibody to the Hib Capsular Polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Genes Associated with the G2m(23) Immunoglobulin Allotype Regulate the IgG Subclass Responses to Haemophilus influenzae Type b Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Six newly recognized types of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

A Longitudinal Study of the Nasopharyngeal Carriage of Pneumococci as Related to Pneumococcal Vaccination in Children Attending Day-care Centres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Bacteriology and clinical relevance of nasopharyngeal and oropharyngeal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Effect of priming with carrier on response to conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Epidemiology and prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Meningococcal vaccines. Current status and future possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Shift in the age-distribution of meningococcal disease as predictor of an epidemic?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Vaccine against meningococcal group B disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Complement-Mediated Bactericidal Activity of Human Antibodies to Poly 2->8 N-Acetylneuraminic Acid, the Capsular Polysaccharide of Neisseria meningitidis Serogroup B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900232-7

7 January 2021

10.1016/S0264-410X(99)00232-7

Identifiers

DOI

1 reference

29 July 2017

1 reference